About Function Oncology
Function Oncology is a company based in San Diego (United States) founded in 2018 by Christian Schmedt. Function Oncology has raised $28 million across 1 funding round from investors including ARE, Andreessen Horowitz and Casdin Capital. The company has 16 employees as of December 31, 2022. Function Oncology operates in a competitive market with competitors including Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Personalis, among others.
- Headquarter San Diego, United States
- Employees 16 as on 31 Dec, 2022
- Founders Christian Schmedt
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Function Oncology Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$28 M (USD)
in 1 rounds
-
Latest Funding Round
$28 M (USD), Series A
Apr 12, 2023
-
Investors
ARE
& 3 more
-
Employee Count
16
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Function Oncology
Function Oncology has successfully raised a total of $28M through 1 strategic funding round. The most recent funding activity was a Series A round of $28 million completed in April 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Function Oncology
Function Oncology has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Andreessen Horowitz and Casdin Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Locked | Locked | Locked | |
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Locked | Locked | Locked | |
|
Tech startups are funded by S32, a venture capital entity.
|
Locked | Locked | Locked |
Investor details for Function Oncology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Function Oncology
Investment portfolio details for Function Oncology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Function Oncology
Detailed financials for Function Oncology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Function Oncology Comparisons
Peer comparison for Function Oncology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Function Oncology
Function Oncology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, Poseida Therapeutics, Castle Biosciences, Juno Therapeutics and Personalis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| Locked | Locked | Locked |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| Locked | Locked | Locked |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| Locked | Locked | Locked |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| Locked | Locked | Locked |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
Detailed competitors of Function Oncology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Function Oncology
Complete news archive for Function Oncology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Function Oncology
Function Oncology was founded in 2018 and raised its 1st funding round 5 years after it was founded.
Function Oncology is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Function Oncology is a funded company, having raised a total of $28M across 1 funding round to date.
As of Dec 31, 2022, the latest employee count at Function Oncology is 16.
Function Oncology was founded in 2018 and is headquartered in San Diego, United States. Cancer therapeutics are developed by the company within the biotechnology sector. A CRISPR-enabled platform is utilized to analyze cancer mechanisms and create targeted therapies. Operations focus on advancing precision oncology treatments for various cancer types.
Function Oncology's top competitors include Juno Therapeutics, Personalis and Poseida Therapeutics.
Function Oncology has 4 investors. Key investors include ARE, Andreessen Horowitz, Casdin Capital, and S32.